Equities

DarioHealth Corp

DRIO:NAQ

DarioHealth Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.48
  • Today's Change0.01 / 0.68%
  • Shares traded73.07k
  • 1 Year change-54.60%
  • Beta1.6390
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its products include Dario Blood Pressure Monitoring System and Dario Blood Glucose Monitoring Starter Kit. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all its user readings in the Dario App. Its Dario mobile app is a complete, cloud-based solution for personal chronic condition management.

  • Revenue in USD (TTM)20.35m
  • Net income in USD-63.51m
  • Incorporated2011
  • Employees276.00
  • Location
    DarioHealth Corp322 W 57Th St. #33BNEW YORK 10019United StatesUSA
  • Phone+1 (646) 665-4667
  • Fax+1 (845) 818-3588
  • Websitehttps://shop.mydario.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DRIO:NAQ since
announced
Transaction
value
Twill IncDeal completed15 Feb 202415 Feb 2024Deal completed-26.73%35.50m
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
electroCore, Inc.16.03m-18.83m34.58m68.00--4.65--2.16-3.56-3.562.911.240.78471.3528.68235,735.30-92.19-70.73-146.63-88.9682.5175.81-117.49-352.821.49--0.00--86.5774.4215.02---5.88--
Co-Diagnostics Inc6.81m-35.33m34.70m155.00--0.4034--5.09-1.20-1.200.23212.750.06241.203.6343,948.71-32.365.77-33.856.1538.5782.24-518.6810.9410.52--0.000.00-80.09179.54-148.15--101.27--
LENSAR Inc42.16m-14.38m36.92m130.00--1.10--0.8756-1.34-1.343.774.160.67231.547.65324,338.50-22.93-30.97-28.10-36.9450.0651.04-34.11-52.302.64--0.00--19.2511.5727.77---42.91--
BioRegenx Inc22.24k-571.17k38.27m10.00------1,720.56-0.0021-0.00210.00008-0.00080.4899----2,224.00-1,258.22------96.85---2,568.21-----13.2366.29---47.25---629.37------
iCAD Inc17.32m-7.01m39.01m67.00--1.16--2.25-0.2742-0.19250.67471.270.37190.80342.16258,477.60-15.06-23.94-19.23-34.1485.3776.96-40.48-45.024.26--0.00---12.54-7.5329.32--23.88--
Cutera Inc212.37m-150.83m42.32m540.00------0.1993-7.57-7.5710.68-8.010.48482.424.78---34.43-20.98-43.99-29.2128.4549.47-71.02-26.072.44-46.541.62---15.865.47-83.18--86.13--
Milestone Scientific Inc9.83m-6.93m42.90m17.00--5.30--4.37-0.0949-0.09490.13460.10560.78390.851419.53578,085.30-55.68-55.48-73.81-74.7269.1363.97-71.04-88.942.21--0.0013--11.600.423320.41---7.99--
DarioHealth Corp20.35m-63.51m43.57m276.00--0.6921--2.14-2.24-2.240.71742.140.18882.214.2573,739.13-55.13-73.26-64.69-87.5929.4029.54-292.00-293.543.38--0.3293---26.4122.450.5091--52.42--
United Health Products Inc0.00-2.62m44.43m6.00---------0.011-0.0110.00-0.0070.000.00--0.00-826.01-6,446.86------53.19---132,561.200.0606-20.88-----100.00---55.45------
Cytosorbents Corp36.35m-28.51m44.48m186.00--1.91--1.22-0.6375-0.63750.81320.42910.62413.916.20195,426.80-48.94-36.00-61.82-43.5261.6068.15-78.43-62.711.51--0.1781--4.7910.0613.12---9.24--
IRIDEX Corp51.87m-9.57m46.65m111.00--4.90--0.8993-0.5934-0.59343.220.58591.352.938.01467,288.30-24.95-19.54-37.31-27.4642.0442.67-18.45-15.451.35--0.00---8.964.02-26.81---24.35--
InspireMD Inc6.21m-19.92m46.80m65.00--1.11--7.54-1.08-1.080.25651.810.17172.364.3795,461.54-55.10-60.59-65.08-72.9729.1220.46-320.97-334.786.99--0.00--20.0011.50-7.71--41.57--
Vaso Corp81.02m4.81m49.79m300.009.461.858.580.61450.030.030.46260.15311.1020.686.03270,080.006.527.6011.1916.6262.4458.395.935.821.45--0.0043--2.181.84-57.46---22.33--
Apyx Medical Corp52.35m-18.71m50.23m252.00--1.88--0.9596-0.5403-0.54031.510.77070.79911.714.25207,734.10-28.78-25.24-35.57-29.9764.4966.11-36.01-46.004.74-12.810.5526--17.6125.8219.28--7.99--
Heartbeam Inc0.00-14.64m52.66m15.00--3.30-----0.9404-0.94040.000.60530.00----0.00-138.30---159.89--------------0.00-------12.94------
Data as of Apr 26 2024. Currency figures normalised to DarioHealth Corp's reporting currency: US Dollar USD

Institutional shareholders

29.48%Per cent of shares held by top holders
HolderShares% Held
Nantahala Capital Management LLCas of 31 Dec 20232.34m8.59%
Appian Way Asset Management LPas of 31 Dec 20231.32m4.86%
MORE Investment House Ltd.as of 31 Dec 20231.29m4.74%
Phoenix Investments House Ltd.as of 31 Dec 20231.18m4.34%
Clal Pension & Provident Funds Ltd.as of 31 Dec 2023875.96k3.22%
The Vanguard Group, Inc.as of 31 Dec 2023354.97k1.31%
Geode Capital Management LLCas of 31 Dec 2023270.57k1.00%
Clarity Capital Partners LLCas of 31 Dec 2023170.43k0.63%
LPL Financial LLCas of 31 Dec 2023109.90k0.40%
BlackRock Fund Advisorsas of 31 Dec 2023108.19k0.40%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.